The MLKL inhibitor, necrosulfonaminde [134], significantly inhibited docetaxel‐mediated necroptosis in MDA‐MB‐231 breast cancer cells transfected with BAD, validating the role of BAD in the modulation of necroptosis [133]. The gene discussed is BAD; the disease is breast carcinoma.